Miromatrix Medical Inc (MIRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,464 | -14,011 | -7,480 | -29,960 | -23,014 |
| Depreciation Amortization | 654 | 483 | 295 | 1,145 | 841 |
| Other Working Capital | 372 | -539 | -1,504 | 1,088 | 813 |
| Other Operating Activity | 1,183 | 382 | 73 | 1,044 | 733 |
| Operating Cash Flow | $-18,256 | $-13,684 | $-8,616 | $-26,683 | $-20,627 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -33 | -33 | -16 | -1,063 | -856 |
| Purchase Of Investment | -9,743 | -9,743 | N/A | -26,026 | -26,026 |
| Sale Of Investment | 20,000 | 14,000 | 8,000 | 6,000 | N/A |
| Investing Cash Flow | $10,225 | $4,225 | $7,985 | $-21,089 | $-26,882 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -39 | -29 | -15 | -389 | -359 |
| Common Stock Issued | 8,992 | 8,867 | 9,073 | 793 | 778 |
| Other Financing Activity | -15 | -15 | -15 | -236 | -183 |
| Financing Cash Flow | $8,939 | $8,823 | $9,044 | $168 | $236 |
| Beginning Cash Position | 6,008 | 6,008 | 6,008 | 53,612 | 53,612 |
| End Cash Position | 6,916 | 5,372 | 14,420 | 6,008 | 6,338 |
| Net Cash Flow | $908 | $-636 | $8,412 | $-47,604 | $-47,274 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,256 | -13,684 | -8,616 | -26,683 | -20,627 |
| Capital Expenditure | -33 | -33 | -16 | -1,063 | -856 |
| Free Cash Flow | -18,288 | -13,717 | -8,632 | -27,746 | -21,484 |